These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16392213)

  • 1. Stents or surgery: the case for stents.
    Wilson JM
    Tex Heart Inst J; 2005; 32(3):331-8. PubMed ID: 16392213
    [No Abstract]   [Full Text] [Related]  

  • 2. Will drug-eluting stents replace coronary artery bypass surgery?
    Reul RM
    Tex Heart Inst J; 2005; 32(3):323-30. PubMed ID: 16392212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits of drug-eluting stents in coronary heart disease treatment with emphasis on the diabetic subgroup.
    Nguyen MC; Lim YL
    Heart Lung Circ; 2007 Feb; 16(1):7-9. PubMed ID: 17169611
    [No Abstract]   [Full Text] [Related]  

  • 4. Cost-effectiveness of drug-eluting stents.
    Sionis DG; Iakovou IT
    Hellenic J Cardiol; 2006; 47(5):292-7. PubMed ID: 17134064
    [No Abstract]   [Full Text] [Related]  

  • 5. Endovascular haute couture revisited: ready-to-wear comes of age.
    Heuser RR
    Cathet Cardiovasc Diagn; 1998 Nov; 45(3):314. PubMed ID: 9829895
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug-eluting stent implantation: technique matters, more than ever.
    De Bruyne B; Barbato E
    JACC Cardiovasc Interv; 2008 Feb; 1(1):32-3. PubMed ID: 19393141
    [No Abstract]   [Full Text] [Related]  

  • 7. ACC Expert Consensus document on coronary artery stents. Document of the American College of Cardiology.
    Holmes DR; Hirshfeld J; Faxon D; Vlietstra RE; Jacobs A; King SB
    J Am Coll Cardiol; 1998 Nov; 32(5):1471-82. PubMed ID: 9809967
    [No Abstract]   [Full Text] [Related]  

  • 8. Coronary fistulae: which ones deserve treatment, and what kind of treatment do they need?
    Angelini P
    Tex Heart Inst J; 2007; 34(2):202-3. PubMed ID: 17622369
    [No Abstract]   [Full Text] [Related]  

  • 9. Provisional vs primary stenting during percutaneous coronary intervention.
    Ruygrok PN; Webster MW
    Eur Heart J; 2000 Sep; 21(18):1557. PubMed ID: 10973774
    [No Abstract]   [Full Text] [Related]  

  • 10. Endovascular stent-grafting via the aortic arch for distal arch aneurysm: An alternative of endovascular stent-grafting in a complicated case.
    Sueda T; Watari M; Orihashi K; Shikata H; Matsuura Y
    Ann Thorac Cardiovasc Surg; 1999 Jun; 5(3):206-8. PubMed ID: 10413771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. External-to-internal iliac bypass using an endograft-within-wallstent technique.
    Kabutey NK; Deso S; Vilvendhan R; Woodson J; Kim D
    Vasc Endovascular Surg; 2010 Jul; 44(5):372-6. PubMed ID: 20484078
    [No Abstract]   [Full Text] [Related]  

  • 12. Regarding "Stent grafts vs femoropopliteal bypass".
    Takagi H; Tanabashi T; Kawai N; Umemoto T
    J Vasc Surg; 2007 Aug; 46(2):399. PubMed ID: 17664120
    [No Abstract]   [Full Text] [Related]  

  • 13. Perspectives in vascular surgery and endovascular therapy.
    Ricotta JJ; Gloviczki P
    Perspect Vasc Surg Endovasc Ther; 2008 Jun; 20(2):113-4. PubMed ID: 18644801
    [No Abstract]   [Full Text] [Related]  

  • 14. Major adverse cardiac events at long-term follow-up in patients treated with single versus multiple stents during single-vessel percutaneous coronary intervention.
    Sukhija R; Aronow WS; Palaniswamy C; Singh T; Ahn C; Kalapatapu K; Chaturvedi B; Pucillo AL; Sorbera C; Kakar P; Weiss MB; Mehta V; Monsen CE
    J Interv Cardiol; 2009 Oct; 22(5):427-30. PubMed ID: 19627434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regarding "Randomized comparison of percutaneous Viabahn stent grafts vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral arterial occlusive disease".
    Bergqvist D
    J Vasc Surg; 2007 Jul; 46(1):176; author reply 176-7. PubMed ID: 17606139
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug-eluting versus third-generation bare metal stents: the US strategy.
    Isenbarger DW; Resar JR
    Int J Cardiovasc Intervent; 2005; 7(4):171-5. PubMed ID: 16373262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Commentary: new generation of covered stents for the treatment of intracranial aneurysms.
    Taylor RA; Qureshi AI
    J Endovasc Ther; 2010 Feb; 17(1):66-7. PubMed ID: 20199269
    [No Abstract]   [Full Text] [Related]  

  • 18. Endovascular management of saphenous vein graft aneurysm: mutidisciplinary approach to a complex problem.
    Stone PA; Lewis SA; Campbell JE; Baker N; Phang D; Deel JT
    Vasc Endovascular Surg; 2012 Oct; 46(7):555-8. PubMed ID: 22889678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility and cost of treatment with drug eluting stents of surgical candidates with multi-vessel coronary disease.
    Griffiths H; Bakhai A; West D; Petrou M; De Souza T; Moat N; Pepper J; Di Mario C
    Eur J Cardiothorac Surg; 2004 Sep; 26(3):528-34. PubMed ID: 15302047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial of an external Dacron sheath for the prevention of vein graft disease: the Extent study.
    Murphy GJ; Newby AC; Jeremy JY; Baumbach A; Angelini GD
    J Thorac Cardiovasc Surg; 2007 Aug; 134(2):504-5. PubMed ID: 17662798
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.